Oral and Maxillofacial Surgery Registrar, Dunedin Hospital, Dunedin, New Zealand.
Department of Oral Diagnostic and Surgical Sciences, University of Otago, Dunedin, New Zealand.
Oral Maxillofac Surg. 2024 Dec;28(4):1595-1603. doi: 10.1007/s10006-024-01290-7. Epub 2024 Aug 30.
This research aimed to investigate the relative frequency of odontogenic tumours (OT) and selected odontogenic cysts in a single oral pathology center in New Zealand from 2008 to 2023.
Histopathological records from the Oral Pathology Centre, University of Otago (2008-2023) were examined to identify OT. Odontogenic keratocyst (OKC) and calcifying odontogenic cyst (COC), previously classified as OT were also included. Patient demographics, clinical details and histopathologic diagnoses were recorded. Data were analyzed using SPSS.
Of the 34,225 biopsies over the 15-year period, 1.8% were identified as OTs, COC and OKCs and accounted for 47%, 1.5% and 51.5% respectively. The most prevalent OT types were odontoma (43.7%), ameloblastoma (27%) and cemento-ossifying fibroma (7.5%). Malignant OT, ameloblastic carcinoma, constituted 1.4% of OT. The average age at diagnosis for OKC, COC and OT patients were 48.2 ± 20.9, 33.7 ± 23.3 and 28.9 ± 19.3 years. Overall, male and mandibular site predilections were observed. Recurrence of OKC and ameloblastoma occurred in 15.2% and 13.7% of patients. The time for recurrence for OKC and Ameloblastoma were 61.7 ± 56.5 months and 122 ± 152 months respectively.
The demographic features and range of OT, COC and OKC in New Zealand align with those of other western countries. The study also confirms need for long term follow up for patient with OKC and ameloblastoma.
本研究旨在调查新西兰一个口腔病理学中心 2008 年至 2023 年期间牙源性肿瘤(OT)和选定的牙源性囊肿的相对频率。
检查奥塔哥大学口腔病理学中心(2008-2023 年)的组织病理学记录,以确定 OT。也包括以前归类为 OT 的牙源性角化囊肿(OKC)和钙化性牙源性囊肿(COC)。记录患者的人口统计学、临床详细信息和组织病理学诊断。使用 SPSS 分析数据。
在 15 年期间的 34225 个活检中,有 1.8%被确定为 OTC、COC 和 OKCs,分别占 47%、1.5%和 51.5%。最常见的 OT 类型是牙瘤(43.7%)、成釉细胞瘤(27%)和骨化性纤维瘤(7.5%)。恶性 OT,成釉细胞癌,占 OT 的 1.4%。OKC、COC 和 OT 患者的平均诊断年龄分别为 48.2±20.9、33.7±23.3 和 28.9±19.3 岁。总体而言,观察到男性和下颌部位偏好。OKC 和成釉细胞瘤的复发率分别为 15.2%和 13.7%。OKC 和成釉细胞瘤的复发时间分别为 61.7±56.5 个月和 122±152 个月。
新西兰的 OT、COC 和 OKC 的人口统计学特征和范围与其他西方国家一致。该研究还证实了需要对 OKC 和成釉细胞瘤患者进行长期随访。